# Intravenous Dexmeditomidine for Prevention of Spinal Anesthesia Induced Shivering.

> **NCT05342376** · PHASE4 · UNKNOWN · sponsor: **Rehman Medical Institute - RMI** · enrollment: 80 (estimated)

## Conditions studied

- Postoperative Shivering
- Cesarean Delivery

## Interventions

- **DRUG:** Dexmedetomidine Hydrochloride
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT05342376
- **Lead sponsor:** Rehman Medical Institute - RMI
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-01
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-12-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2022-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05342376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05342376, "Intravenous Dexmeditomidine for Prevention of Spinal Anesthesia Induced Shivering.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05342376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*